Acasti Pharma reported $1000 in Ordinary Share Capital for its fiscal quarter ending in December of 2024.


Ordinary Share Capital Change Date
Acasti Pharma USD 1000 261.04M Dec/2024
Addus HomeCare USD 18.4M 18.38M Jun/2025
Amarin USD 308.15M 2.85M Mar/2025
Cassava Sciences USD 48.31M 48.26M Jun/2025
Knight Therapeutics CAD 539.32M 1.63M Sep/2024
Option Care Health USD 162.29M 162.28M Jun/2025
Organigram Holdings CAD 134.02M 758.57M Jun/2025
Tilray USD 93K 5K Nov/2024